Lecture 9: Genetic Screening Flashcards
1. Discuss factors to consider when developing and implementing a new screening test 2. Describe and discuss prenatal screening in the clinical management of Down Syndrome and neural tube defects 3. Describe and discuss the role of screening in the clinical management of cystic fibrosis and phenylketonuria 4. Describe and discuss genetic screening strategies for adults using the example of familial hypercholesterolemia
what are the specific issues with genetic screening based on?
- Permanent results
- Implications for family members
Explain what ACCEE is
- Analytical validity – how well does the test measure what it aims to measure?
- Does it measure what we want to measure
- Clinical validity – how well does the test predict future health?
- Pharmacogenetics-> used to predict response to drugs
- Clinical utility – does the test alter health outcomes?
- Is health outcomes affected?
- Ethical validity – is the test ethical?
- Collection of sample could be ethically invalid
- Outcome of test leaves patient limited to option- e.g, can’t do abortion because forbidden by their culture = leaves only to carry on pregnancy
- Taking multiple sample from someone who doesn’t understand what is happening-> ethical?
- Economics – is it financially viable?
- Cost of obtaining + analysing sample
- E.g, cff DNA less invasive-> less use of specialist equipment for invasive testing= viable
Define true positive
Test positive+ has condition
Define false positive
Test positive+ doesn’t have condition
Define false negative
Test negative+ has condition
Define true negative
Test negative+ doesn’t have condition
Define and give equation for sensitivity
- Sensitivity: ability to detect the condition out of all the people who have the condition
Define and give equation for specificity
- Specificity: detects someone without the condition out of all the people who do not have the condition
Define and give equation for false positive
- False positive: test result is positive yet the person does not have the condition. Given as a proportion of the whole population
Define and give equation for false negative
- False negative: test result is negative yet the person does have the condition. Given as a proportion of the whole population
Explain how who should be screened is determined
- Whole population-> not economically viable for all diseases
- Targeted populations
- Age
- Definition of ‘old age’
- can be not definitive-> out + close to boundaries of age range + still be or offspring affected= DS
- Race
- particular disease can be viewed as ‘bad trait’ associated with race
- E.g, sickle cell anaemia prominent with Afro-Caribbean race
- Can become ostracised + affect employability once declared publicly
- Family history
- E.g, Ashkenazi Jews prone to breast cancer
- Amish pop. is small community-> interbreeding
Explain what NICE is and their role
- Provide national guidance and advice to improve health and social care
- Make recommendations on the use of new medicines and medical technologies
- Define healthcare pathways
List the factors to consider when implementing a new test
- ACCEE \+ - disease incidence - disease pathology - turnaround time - sample + analysis
Describe what the foetal anomaly screening programme detects
- Neural tube defects: anencephaly, spina bifida
- Organ development: heart abnormalities, renal agenesis
- Agenesis:failure of an organ to develop during embryonic growth and development
- Skeletal dysplasia – achrondroplasia
- Skeletal dysplasia: abnormalities of cartilage and bone growth, resulting in abnormal shape and size of the skeleton
- Achrondroplasia: bone growth disorder that causes disproportionate dwarfism
- Cleft lip/palate, diaphragamatic hernia, abdominal wall
- Cleft lip/palate: gap or split in the upper lip and/or roof of the mouth
- Diaphragamatic hernia: hole in the diaphragm-> Organs in the abdomen move through hole + upwards into a baby’s chest
- Trisomy 18, Trisomy 13, Trisomy 21
- T18= Edward’s syndrome
- T13= Patau’s syndrome
- T21= DS
Explain how foetal anomalies are screened
- Biochemical analysis of maternal serum
- Ultrasound scans, 10-14- and 18-21-weeks gestation
10-14= done for mum to identify gestational diabetes + HIV that can be passed onto offspring + dating scan (how far long)
18-21= done for detecting foetal anomalies